NEXT Oncology ( Site 0151) — San Antonio, Texas

Public research footprint of NEXT Oncology ( Site 0151), compiled from the ClinicalTrials.gov public registry.

257

Registered studies

134

Active

103

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced Solid Tumor · NSCLC (Advanced Non-small Cell Lung Cancer) · Advanced Solid Tumors · mCRPC (Metastatic Castration-resistant Prostate Cancer)

Recently updated registry entries

NCT07444814 — Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug… (Recruiting)
NCT07021066 — Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects… (Active Not Recruiting)
NCT04958239 — A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at NEXT Oncology ( Site 0151)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.